Back to Search
Start Over
Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya
- Source :
- Vaccine
- Publication Year :
- 2015
- Publisher :
- Elsevier, 2015.
-
Abstract
- Highlights • We report on the characteristics of RSV neutralising antibodies in a birth cohort. • The levels of cord RSV antibodies increase during seasonal virus transmission. • The rate of decay of RSV antibodies following birth is independent of cord titre. • There is a high degree of variation between individuals in rate of decay. • Important baseline data to maternal RSV vaccine development are provided.<br />Background Severe respiratory syncytial virus (RSV) disease occurs predominantly in children under 6 months of age. There is no licensed RSV vaccine. Protection of young infants could be achieved by a maternal vaccine to boost titres of passively transferred protective antibodies. Data on the level and kinetics of functional RSV-specific antibody at birth and over the early infant period would inform vaccine product design. Methods From a birth cohort study (2002–2007) in Kilifi, Kenya, 100 participants were randomly selected for whom cord blood and 2 subsequent 3-monthly blood samples within the first year of life, were available. RSV antibodies against the A2 strain of RSV were assayed and recorded as the logarithm (base 2) plaque reduction neutralisation test (PRNT) titre. Analysis by linear regression accounted for within-person clustering. Results The geometric mean neutralisation antibody titre was 10.6 (SD: 1.13) at birth with a log-linear decay over the first 6 months of life. The estimated rate of decay was −0.58 (SD: 0.20) log2PRNT titre per month and a half-life of 36 days. There was no significant interaction between cord titre and rate of decay with age. Mean cord titres rose and fell in a pattern temporally tracking community virus transmission. Conclusions In this study population, RSV neutralising antibody titres decay approximately two-fold every one month. The rate of decay varies widely by individual but is not related to titre at birth. RSV specific cord titres vary seasonally, presumably due to maternal boosting.
- Subjects :
- Rsv vaccine
Time Factors
viruses
Respiratory Syncytial Virus Infections
Disease
Respiratory syncytial virus
Antibodies, Viral
Article
Neutralization
Virus
Neutralisation
Cohort Studies
Maternal antibody
Neutralization Tests
Immunology and Microbiology(all)
Humans
Respiratory system
Vaccine design
General Veterinary
General Immunology and Microbiology
biology
Public Health, Environmental and Occupational Health
virus diseases
Infant
respiratory system
Fetal Blood
veterinary(all)
Antibodies, Neutralizing
Kenya
Virology
3. Good health
Rate of decay
Infectious Diseases
Respiratory Syncytial Virus, Human
Immunology
biology.protein
Molecular Medicine
Female
Seasons
Antibody
Birth cohort
Immunity, Maternally-Acquired
Half-Life
Cohort study
Subjects
Details
- Language :
- English
- ISSN :
- 0264410X
- Database :
- OpenAIRE
- Journal :
- Vaccine
- Accession number :
- edsair.doi.dedup.....cc459614cb53b81b16aa2a597aa96467